220 related articles for article (PubMed ID: 29629840)
1. Proteomics detection of S100A6 in tumor tissue interstitial fluid and evaluation of its potential as a biomarker of cholangiocarcinoma.
Onsurathum S; Haonon O; Pinlaor P; Pairojkul C; Khuntikeo N; Thanan R; Roytrakul S; Pinlaor S
Tumour Biol; 2018 Apr; 40(4):1010428318767195. PubMed ID: 29629840
[TBL] [Abstract][Full Text] [Related]
2. S100A6 promotes proliferation of intrahepatic cholangiocarcinoma cells via the activation of the p38/MAPK pathway.
Zheng S; Shen H; Jia Q; Jing C; Lin J; Zhang M; Zhang X; Zhang B; Liu Y
Future Oncol; 2017 Oct; 13(23):2053-2063. PubMed ID: 28984474
[TBL] [Abstract][Full Text] [Related]
3. Differential LC-MS-based proteomics of surgical human cholangiocarcinoma tissues.
Kawase H; Fujii K; Miyamoto M; Kubota KC; Hirano S; Kondo S; Inagaki F
J Proteome Res; 2009 Aug; 8(8):4092-103. PubMed ID: 19569727
[TBL] [Abstract][Full Text] [Related]
4. S100 calcium binding protein A6 and associated long noncoding ribonucleic acids as biomarkers in the diagnosis and staging of primary biliary cholangitis.
Dong XH; Dai D; Yang ZD; Yu XO; Li H; Kang H
World J Gastroenterol; 2021 May; 27(17):1973-1992. PubMed ID: 34007134
[TBL] [Abstract][Full Text] [Related]
5. Tissue mRNA for S100A4, S100A6, S100A8, S100A9, S100A11 and S100P Proteins in Colorectal Neoplasia: A Pilot Study.
Peterova E; Bures J; Moravkova P; Kohoutova D
Molecules; 2021 Jan; 26(2):. PubMed ID: 33466593
[TBL] [Abstract][Full Text] [Related]
6. Comparative Proteomic Analysis of Human Cholangiocarcinoma Cell Lines: S100A2 as a Potential Candidate Protein Inducer of Invasion.
Wasuworawong K; Roytrakul S; Paemanee A; Jindapornprasert K; Komyod W
Dis Markers; 2015; 2015():629367. PubMed ID: 25999659
[TBL] [Abstract][Full Text] [Related]
7. Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients.
Wei BR; Hoover SB; Ross MM; Zhou W; Meani F; Edwards JB; Spehalski EI; Risinger JI; Alvord WG; Quiñones OA; Belluco C; Martella L; Campagnutta E; Ravaggi A; Dai RM; Goldsmith PK; Woolard KD; Pecorelli S; Liotta LA; Petricoin EF; Simpson RM
PLoS One; 2009 Oct; 4(10):e7670. PubMed ID: 19888321
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation, modification, and translocation of S100A6 induced by exposure to ionizing radiation revealed by proteomics profiling.
Orre LM; Pernemalm M; Lengqvist J; Lewensohn R; Lehtiö J
Mol Cell Proteomics; 2007 Dec; 6(12):2122-31. PubMed ID: 17785350
[TBL] [Abstract][Full Text] [Related]
9. High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma.
Chua-On D; Proungvitaya T; Techasen A; Limpaiboon T; Roytrakul S; Wongkham S; Wongkham C; Somintara O; Sungkhamanon S; Proungvitaya S
Tumour Biol; 2016 Oct; 37(10):13659-13667. PubMed ID: 27473083
[TBL] [Abstract][Full Text] [Related]
10. S100A6 drives lymphatic metastasis of liver cancer via activation of the RAGE/NF-kB/VEGF-D pathway.
Chen T; Ruan Y; Ji L; Cai J; Tong M; Xue Y; Zhao H; Cai X; Xu J
Cancer Lett; 2024 Apr; 587():216709. PubMed ID: 38350547
[TBL] [Abstract][Full Text] [Related]
11. A prospective proteomic-based study for identifying potential biomarkers for the diagnosis of cholangiocarcinoma.
Shi Y; Deng X; Zhan Q; Shen B; Jin X; Zhu Z; Chen H; Li H; Peng C
J Gastrointest Surg; 2013 Sep; 17(9):1584-91. PubMed ID: 23868055
[TBL] [Abstract][Full Text] [Related]
12. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue.
Haslene-Hox H; Oveland E; Woie K; Salvesen HB; Wiig H; Tenstad O
Biochim Biophys Acta; 2013 Nov; 1834(11):2347-59. PubMed ID: 23707566
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of S100A6 in patients with endometriosis and its role in ectopic endometrial stromal cells.
Peng Y; Lin J; Ma J; Lin K; Xu K; Lin J
Gynecol Endocrinol; 2018 Sep; 34(9):815-820. PubMed ID: 29544367
[TBL] [Abstract][Full Text] [Related]
14. Identification of TPD52 and DNAJB1 as two novel bile biomarkers for cholangiocarcinoma by iTRAQ‑based quantitative proteomics analysis.
Ren H; Luo M; Chen J; Zhou Y; Li X; Zhan Y; Shen D; Chen B
Oncol Rep; 2019 Dec; 42(6):2622-2634. PubMed ID: 31661142
[TBL] [Abstract][Full Text] [Related]
15. Secretomic profiling of cells from hollow fiber bioreactor reveals PSMA3 as a potential cholangiocarcinoma biomarker.
Verathamjamras C; Weeraphan C; Chokchaichamnankit D; Watcharatanyatip K; Subhasitanont P; Diskul-Na-Ayudthaya P; Mingkwan K; Luevisadpaibul V; Chutipongtanate S; Champattanachai V; Svasti J; Srisomsap C
Int J Oncol; 2017 Jul; 51(1):269-280. PubMed ID: 28560424
[TBL] [Abstract][Full Text] [Related]
16. [Regulation mechanism study of S100A6 on invasion and metastasis in gastric cancer].
Li J; Wang XH; Li ZY; Bu ZD; Wu AW; Zhang LH; Wu XJ; Zong XL; Ji JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Nov; 16(11):1096-101. PubMed ID: 24277409
[TBL] [Abstract][Full Text] [Related]
17. Shotgun proteomics of human bile in hilar cholangiocarcinoma.
Farid SG; Craven RA; Peng J; Bonney GK; Perkins DN; Selby PJ; Rajendra Prasad K; Banks RE
Proteomics; 2011 May; 11(10):2134-8. PubMed ID: 21500345
[TBL] [Abstract][Full Text] [Related]
18. The Role of S100A6 in Human Diseases: Molecular Mechanisms and Therapeutic Potential.
Yang F; Ma J; Zhu D; Wang Z; Li Y; He X; Zhang G; Kang X
Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509175
[TBL] [Abstract][Full Text] [Related]
19. Upregulated expression of S100A6 in human gastric cancer.
Yang YQ; Zhang LJ; Dong H; Jiang CL; Zhu ZG; Wu JX; Wu YL; Han JS; Xiao HS; Gao HJ; Zhang QH
J Dig Dis; 2007 Nov; 8(4):186-93. PubMed ID: 17970874
[TBL] [Abstract][Full Text] [Related]
20. S100A6 expression and function in human osteosarcoma.
Luo X; Sharff KA; Chen J; He TC; Luu HH
Clin Orthop Relat Res; 2008 Sep; 466(9):2060-70. PubMed ID: 18612712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
